Hint mode is switched on Switch off
For swift navigation between sections

Circa
LEI 549300TYMT7PQV920R92

PDF download

Choose all Reset all
Download Cancel
Organization name
Circa Group AS
Country name
Norway
Country of registration
Norway
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Circa Group AS is a biotechnology company that has spent 15 years and five pilots to develop and patent the first scalable LGO production process. LGO is a platform biomolecule used in production of pharmaceuticals, agrochemicals, batteries, graphene, polymers and more.

Awards

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300TYMT7PQV920R92
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • NACE
    *** ***
  • NAICS
    *** ***
  • Organisasjonsnummer
    926 168 061
Registration is required to get access.